LCP
LLY icon

Legacy Capital Partners’s Eli Lilly LLY Stock Holding History

Legacy Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$284K Sell
992
-25
-2% -$6.43K 0.09% 123
2021
Q4 		$281K Sell
1,017
-90
-8% -$22.8K 0.09% 130
2021
Q3 		$256K Sell
1,107
-500
-31% -$123K 0.09% 127
2021
Q2 		$369K Sell
1,607
-100
-6% -$20.1K 0.13% 115
2021
Q1 		$319K Hold
1,707
– – 0.12% 116
2020
Q4 		$288K Sell
1,707
-660
-28% -$98.5K 0.11% 120
2020
Q3 		$350K Hold
2,367
– – 0.14% 105
2020
Q2 		$389K Buy
2,367
+34
+1% +$5.22K 0.17% 102
2020
Q1 		$324K Buy
2,333
+50
+2% +$6.87K 0.16% 98
2019
Q4 		$300K Hold
2,283
– – 0.12% 117
2019
Q3 		$255K Sell
2,283
-100
-4% -$11.1K 0.11% 131
2019
Q2 		$264K Sell
2,383
-42
-2% -$4.95K 0.12% 123
2019
Q1 		$315K Buy
2,425
+242
+11% +$29.4K 0.15% 105
2018
Q4 		$253K Buy
+2,183
New +$244K 0.13% 113
2016
Q3 		– Sell
-5,075
Closed -$400K – 113
2016
Q2 		$400K Buy
5,075
+300
+6% +$22.6K 0.25% 88
2016
Q1 		$344K Buy
4,775
+76
+2% +$5.75K 0.22% 88
2015
Q4 		$396K Buy
4,699
+203
+5% +$16.8K 0.25% 83
2015
Q3 		$377K Sell
4,496
-600
-12% -$50.7K 0.26% 85
2015
Q2 		$426K Buy
5,096
+326
+7% +$24.8K 0.28% 84
2015
Q1 		$347K Sell
4,770
-500
-9% -$35.6K 0.22% 91
2014
Q4 		$364K Hold
5,270
– – 0.23% 85
2014
Q3 		$342K Sell
5,270
-500
-9% -$31.7K 0.23% 82
2014
Q2 		$359K Hold
5,770
– – 0.23% 83
2014
Q1 		$340K Sell
5,770
-350
-6% -$19.5K 0.24% 85
2013
Q4 		$313K Sell
6,120
-1,000
-14% -$50.1K 0.22% 89
2013
Q3 		$359K Sell
7,120
-582
-8% -$30.5K 0.27% 80
2013
Q2 		$379K Buy
+7,702
New +$419K 0.29% 76

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Legacy Capital Partners's LLY Position: Q1 2022 in Review

Legacy Capital Partners reduced its Eli Lilly (LLY) stake by 2.5% in Q1 2022, selling an estimated $6.43K and leaving 992 shares worth $284K. The position accounts for 0.09% of the portfolio, ranked #123.

Legacy Capital Partners first reported a position in LLY in Q2 2013 and has held it in 27 quarters since. The position peaked at $426K in Q2 2015. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Legacy Capital Partners held 992 shares of Eli Lilly worth $284K as of Q1 2022.
  • Legacy Capital Partners sold 25 Eli Lilly shares in Q1 2022, an estimated $6.43K.
  • Eli Lilly made up 0.09% of Legacy Capital Partners's portfolio in Q1 2022, its #123 holding.
  • Legacy Capital Partners first reported a position in Eli Lilly in Q2 2013 and has held it in 27 quarters since.
  • Legacy Capital Partners's Eli Lilly position peaked at $426K in Q2 2015.
  • 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Legacy Capital Partners's 13F filing for Q1 2022, filed 11 Apr 2022.